Molecular Diversity and Evolution of bla TEM Genes Encoding β-Lactamases Resistant to Clavulanic Acid in Clinical E. coli
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Evolution
- Vol. 44 (1) , 57-65
Abstract
The molecular diversity of inhibitor-resistant TEM (IRT) enzymes was explored using a strategy which involved DNA amplification by polymerase chain reaction (PCR), analysis of restriction fragment length polymorphism (RFLP), and direct nucleotide sequencing. The study of plasmid-borne genes from 27 strains, resistant to amoxicillin and β-lactamase-inhibitor combinations, identified mutations resulting in amino acid change at positions 69, 244, 275, and 276 known to be associated with the IRT phenotype and a mutation at nucleotide position 162 in the promoter region. These mutations were found to lie on two different gene sequences, described here as ``TEM-1B like'' and ``TEM-2 like'' restriction linkage groups. Further analysis, of nucleotide sequences of promoter and coding regions of the β-lactamases, confirmed that a given mutation causing IRT phenotype could be associated with two different gene sequence frameworks and two different causal mutations could lie on identical gene sequence framework. These data argue in favor of convergent phenotypic evolution of IRT enzymes under the selective pressure imposed by the intensive clinical use of β-lactam–β-lactamase inhibitor combinations.Keywords
This publication has 33 references indexed in Scilit:
- Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitorsFEMS Microbiology Letters, 1994
- Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)FEMS Microbiology Letters, 1994
- Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activityJournal of Antimicrobial Chemotherapy, 1994
- Survey of the prevalence of βlactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London HospitalJournal of Antimicrobial Chemotherapy, 1992
- Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1992
- Mismatch PCR: a rapid method to screen for the Pro207 → Leu mutation in the lipoprotein lipase (LPL) geneHuman Molecular Genetics, 1992
- OHIO-1 β-lactamase resistant to mechanism-based inactivatorsFEMS Microbiology Letters, 1992
- TRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strainFEMS Microbiology Letters, 1992
- Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- Penicillinase Synthesis Controlled By Infectious R Factors In EnterobacteriaceaeNature, 1965